Harvard researcher quits Shaklee
A Harvard professor and the California-based Shaklee Corp. differ on whether he approved the use of his name to promote a purportedly life-extending syrup.
David Sinclair, a anti-aging researcher at Harvard Medical School, disputes Shaklee’s contention that he approved use of his name in advertisements for the Vivix Cellular Anti-Aging Tonic, The Wall Street Journal reported Friday.
Sinclair resigned from Shaklee’s advisory board last week after the Journal questioned his seeming endorsement of Vivex, which costs $100 for a month’s supply and is made of resveratrol, a chemical found in red wine.
Shaklee Corp. calls Vivix
the world’s best anti-aging supplement and asks on its Web site,
How would you like to feel 25 years younger and live 25 years longer?
The question is rhetorical and is designed to
engage people in a dialogue, not guarantee longer life, said Shaklee Chief Executive Roger Barnett.
In studies, resveratrol has proven beneficial in mice, not people, the Journal noted.